?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Resource type:
Biosimilars Educational Resources
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
September 26, 2022
signalgroup
Biosimilars: Non-Medical Switching and Transitioning
September 15, 2021
signalgroup
Separate Codes and Payment for Biosimilars
June 14, 2021
signalgroup
Biosimilars Have Significantly Lowered Prices of All Biologics
October 3, 2019
signalgroup
FDA Patient Materials
July 3, 2019
Katie Quinn
Biosimilars FAQs
July 3, 2019
Katie Quinn
Biosimilars Overview
July 3, 2019
Katie Quinn
Analysis Shows Biosimilars Lower Patient Costs
March 19, 2019
Katie Quinn
Structural Market Changes Needed to Achieve Cost-Savings from Biosimilars
October 3, 2018
Katie Quinn
Science-Based Resource on the Basic Facts About Biosimilars